Overview
Nuvectra was a publicly traded neurostimulation company that developed the Algovita spinal cord stimulation system for chronic pain management. The company also had DBS and sacral neuromodulation platforms under development before ceasing operations.
More in Brain-Computer Interfaces
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-09-23 · Policy
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Company details
Category
🧠 Brain-Computer Interfaces
Location
Allen, USA
Funding
Public · NASDAQ: NVTR (ceased operations)
Website
nuvectra.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →